SUBSEQUENT EVENT |
9 Months Ended |
|---|---|
Oct. 03, 2026 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENT |
NOTE N – SUBSEQUENT EVENT
On July 17, 2026, the Company entered into a binding contract for the sale of its owned office and warehouse facility located in Castle Hill, New South Wales, Australia for a gross sale price of $17,984. The sale settled on October 12, 2026, subsequent to the end of the Company’s third fiscal quarter, with net cash proceeds of approximately $16,080 and an estimated pre-tax gain of $8,230 to be recognized in the fourth quarter of 2026. As of October 3, 2026, the criteria for held-for-sale classification had not yet been fully satisfied due to continuing operational use of the facility by Company personnel and therefore the real property included in the sale remained classified within property and equipment, net on the condensed consolidated balance sheet. Approximately $7,850 of property and equipment net book value from the sale was removed in October 2026 and the Company repatriated $12,041 of the net proceeds to USANA Health Sciences, Inc. through an intercompany dividend from its Australian subsidiary, USANA Australia Pty Ltd.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|